These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 11287873

  • 21. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults.
    Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Kokudo N, Makuuchi M.
    Transpl Infect Dis; 2009 Feb; 11(1):11-9. PubMed ID: 18811632
    [Abstract] [Full Text] [Related]

  • 22. Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
    Mammina C, Di Carlo P, Cipolla D, Casuccio A, Tantillo M, Plano MR, Mazzola A, Corsello G.
    Acta Pharmacol Sin; 2008 Dec; 29(12):1486-92. PubMed ID: 19026168
    [Abstract] [Full Text] [Related]

  • 23. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa.
    Ray GT, Baxter R, DeLorenze GN.
    Clin Infect Dis; 2005 Aug 15; 41(4):441-9. PubMed ID: 16028150
    [Abstract] [Full Text] [Related]

  • 24. Urinary tract infection. Diabetics and non-diabetic patients.
    Akbar DH.
    Saudi Med J; 2001 Apr 15; 22(4):326-9. PubMed ID: 11331489
    [Abstract] [Full Text] [Related]

  • 25. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR, Pressler T, Koch C, Høiby N.
    J Cyst Fibros; 2005 Mar 15; 4(1):35-40. PubMed ID: 15752679
    [Abstract] [Full Text] [Related]

  • 26. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E, De Silvestri A, Boschi A, Tinelli C.
    AIDS Rev; 2008 Mar 15; 10(4):236-44. PubMed ID: 19092979
    [Abstract] [Full Text] [Related]

  • 27. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, Ramos F, Goldani LZ.
    J Antimicrob Chemother; 2006 Aug 15; 58(2):387-92. PubMed ID: 16751638
    [Abstract] [Full Text] [Related]

  • 28. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
    Pressler T, Frederiksen B, Skov M, Garred P, Koch C, Høiby N.
    J Cyst Fibros; 2006 Jan 15; 5(1):9-15. PubMed ID: 16412706
    [Abstract] [Full Text] [Related]

  • 29. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
    Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE, Adult and Adolescent Spectrum of HIV Disease Project.
    Clin Infect Dis; 2001 Mar 01; 32(5):794-800. PubMed ID: 11229848
    [Abstract] [Full Text] [Related]

  • 30. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R.
    Am J Infect Control; 2006 May 01; 34(4):188-92. PubMed ID: 16679175
    [Abstract] [Full Text] [Related]

  • 31. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States.
    Fry AM, Facklam RR, Whitney CG, Plikaytis BD, Schuchat A.
    J Infect Dis; 2003 Sep 01; 188(5):643-52. PubMed ID: 12934179
    [Abstract] [Full Text] [Related]

  • 32. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M, Icona Foundation Study Group.
    Clin Infect Dis; 2009 Aug 15; 49(4):612-22. PubMed ID: 19591597
    [Abstract] [Full Text] [Related]

  • 33. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov 15; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 34. Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County.
    Sorvillo F, Beall G, Turner PA, Beer VL, Kovacs AA, Kerndt PR.
    AIDS; 1997 Apr 15; 11(5):673-9. PubMed ID: 9108950
    [Abstract] [Full Text] [Related]

  • 35. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
    Ozkurt Z, Ertek M, Erol S, Altoparlak U, Akcay MN.
    Burns; 2005 Nov 15; 31(7):870-3. PubMed ID: 15975720
    [Abstract] [Full Text] [Related]

  • 36. [Pseudomonas aeruginosa infections in a neonatal care unit at Reunion Island].
    Gérardin P, Farny K, Simac C, Laurent AF, Grandbastien B, Robillard PY.
    Arch Pediatr; 2006 Dec 15; 13(12):1500-6. PubMed ID: 17049218
    [Abstract] [Full Text] [Related]

  • 37. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    McDonald LC, Lauderdale TL, Lo HJ, Tsai JJ, Hung CC.
    Int J STD AIDS; 2003 Jul 15; 14(7):473-7. PubMed ID: 12869228
    [Abstract] [Full Text] [Related]

  • 38. Outbreak of cystoscopy related infections with Pseudomonas aeruginosa: New Mexico, 2007.
    Wendelboe AM, Baumbach J, Blossom DB, Frank P, Srinivasan A, Sewell CM.
    J Urol; 2008 Aug 15; 180(2):588-92; discussion 592. PubMed ID: 18554660
    [Abstract] [Full Text] [Related]

  • 39. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
    Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L.
    Am J Trop Med Hyg; 2008 Sep 15; 79(3):320-30. PubMed ID: 18784222
    [Abstract] [Full Text] [Related]

  • 40. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM, Araneta MR, Deville JG, Spector SA.
    Clin Infect Dis; 2004 Sep 01; 39(5):725-31. PubMed ID: 15356789
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.